Human papillomavirus type 11 L1 capsid protein antigen
- Generic Name
- Human papillomavirus type 11 L1 capsid protein antigen
- Brand Names
- Gardasil, Gardasil 9
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- Z845VHQ61P
- Background
Human papillomavirus type 11 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) types 6, 11, 16 and 18.
The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, and 18, which are produced by separate fermentations in recombinant Saccharomyces cerevisiae and self-assembled into VLPs.
- Associated Conditions
- Human Papillomavirus (HPV) Infections, Infection caused by human papillomavirus type 11
- Associated Therapies
- -
20 Fastest Growing Health Tech Companies in the World
The digital health market, valued at $180.2 billion in 2023, is expected to grow to $549.7 billion by 2028, driven by technologies like mHealth, telehealth, and digital therapeutics. Key players include DexCom and Teladoc Health, with the US market leading at $88 billion in 2023. Telemedicine and wearable devices are pivotal, with the telemedicine market projected to reach $286.22 billion by 2030. Precision medicine and medical imaging technologies are also transforming healthcare, with companies like Merck & Co., Sanofi, and AstraZeneca leading in innovation and growth.
Top 10 Projected Best-Selling Drugs in 2024
Nature Reviews Drug Discovery forecasts the top 10 pharmaceutical products for 2024, each expected to surpass $10 billion in sales. Leading the list is Keytruda by Merck & Co., with a projected $27.19 billion in sales, followed by Ozempic, Dupixent, Eliquis, Biktarvy, Darzalex, Opdivo, Comirnaty, Gardasil, and Skyrizi. These drugs cover a range of treatments from cancer to diabetes, HIV, and COVID-19, highlighting significant advancements and market potentials in the pharmaceutical industry.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath